Nov. 11, 2020—Twenty-nine prominent faculty from across campus comprise Vanderbilt University’s latest endowed chair honorees. They include scholars working in diverse areas—from election analysis and lung cancer research to the nascent field of neurolaw, exploring the brain mechanism underlying legal decision-making.
Aug. 19, 2020—A bifunctional natural compound has been discovered with the potential to make antibiotic resistance to deadly infections less likely.
Jul. 19, 2019—Chemistry major Puxin Xuanyuan put her creativity to work this summer while splitting time between an immersion experience at a medical biotech startup in Toronto and conducting cancer-fighting research on the Vanderbilt campus.
Deep Healing: Two alumni are making waves in drug discovery by plumbing the oceans’ depths for new therapeutic molecules
Sep. 6, 2018—Sirenas, a San Diego-based company founded by Vanderbilt alumni Eduardo Esquenazi, BS'98, and Jake Beverage, BA'98, is applying trailblazing methods toward drug discovery.
May. 1, 2018—Vanderbilt scientists have developed a new process that can rapidly and inexpensively identify personalized cancer drugs derived from nature.
Dec. 28, 2015—With discoveries ranging from the origins of consciousness to the end of the universe, 2015 was a year of incredibly diverse research at Vanderbilt University.
Aug. 7, 2015—Vanderbilt researchers have discovered how certain molecules with antibiotic properties are synthesized, findings that could lead to new drugs that overcome the increased antibiotic resistance in bacteria.
Jul. 21, 2015—In the latest VUCast: Find out about a fight club that can save lives; learn how musicians see in tune; and see the best Vanderbilt baseball fans from the College World Series. Watch now.
Jun. 29, 2015—Chemists Brian Bachmann and John McLean have shown that creating bacterial "fight clubs" is an effective way to discover natural biomolecules with the properties required for new drugs.
Jan. 27, 2015—Hillsboro High School senior Alex Jolly advanced to the semi-finals in the Intel Science Talent Search with his research project on cave drugs.
Mar. 24, 2014—By shifting evolution into reverse to produce an expensive HIV drug out of a simple sugar, Vanderbilt chemist Brian Bachmann has shown that it may be possible to manufacture exotic and expensive synthetic drugs as easily as brewing beer.
Mar. 3, 2014—Vanderbilt University has been awarded a Cooperative Agreement with the Defense Advanced Research Projects Agency and the Army Research Office that is worth up to $16.5 million over five years.